Updated:
Ivy Fertility Services
Ivy Fertility Services is a San Diego-based investment firm deploying permanent capital into reproductive medicine clinics and platforms.
Ivy Fertility Services
Ivy Fertility Services manages a concentrated portfolio centered on the fertility and reproductive health sector, making direct equity investments in clinic operators and service providers. The firm targets established practices and emerging companies that offer in-vitro fertilization, genetic testing, egg freezing, and surrogacy coordination. Its capital supports expansion into new metropolitan markets and the integration of electronic medical records systems to improve patient outcomes and clinic efficiency. The portfolio emphasizes vertically integrated care models where physicians retain operational autonomy while accessing centralized administrative, legal, and marketing resources. Ivy Fertility typically acquires majority positions, allowing for standardized back-office functions across portfolio companies while preserving the clinical brand equity built by founding physicians. Investments prioritize regions with favorable insurance mandates and demographic tailwinds, including California, Texas, and the Northeast corridor. In September 2024, Ivy Fertility announced its acquisition of a prominent multi-location fertility practice in the Mid-Atlantic, adding three clinics and a state-certified tissue bank to its holdings (per public record, September 2024). This transaction extended the firm's geographic reach into a high-barrier regulatory market and strengthened its capacity for cryopreservation services, a recurring revenue stream across its network. The firm's structure as a single-family office with an exclusive operator lens distinguishes it from generalist healthcare private equity funds that cycle through holding periods. Ivy Fertility retains practices indefinitely, reinvesting earnings into technology upgrades and de novo clinic construction rather than pursuing exit-driven value creation.
General information
Firm type
Single Family Office
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
San Diego
Corporate office
San Diego, CA, United States
Frequently asked questions
How does Ivy Fertility Services invest in the reproductive medicine space?
Ivy Fertility makes direct equity acquisitions of fertility clinics, diagnostic laboratories, and technology platforms. The firm pursues majority stakes and integrates portfolio companies into a shared back-office infrastructure that handles compliance, billing, and marketing, while clinical teams retain operational independence. The model targets established practices with strong local referral networks.
Is Ivy Fertility structured as a traditional private equity fund?
No. Ivy Fertility operates as a family office with a permanent capital base, not a blind-pool private equity fund. It does not raise third-party commitments or operate under fixed investment periods, allowing it to hold assets indefinitely and reinvest operating cash flows into expansion and de novo clinic construction.
Which regions does Ivy Fertility target for clinic acquisitions?
Ivy Fertility prioritizes U.S. markets with favorable state-level insurance mandates for infertility treatment and demographic trends supporting family formation. Its disclosed operations stretch from California through Texas and into the Mid-Atlantic and Northeast corridors, with a recent expansion into a multi-site practice on the East Coast.
What is the firm's approach to physician partners?
Ivy Fertility typically retains founding physicians in active clinical and leadership roles post-acquisition. The firm structures partnerships that preserve the physician group's brand and local patient relationships while assuming administrative functions, legal compliance, and capital for geographic and technological expansion.
Does the firm invest outside of fertility services?
The firm's known deployment is concentrated entirely within the reproductive medicine ecosystem — clinical fertility services, reproductive tissue banking, genetic diagnostics, and related health-tech platforms. There is no public record of investment activity in unrelated healthcare verticals or non-healthcare sectors.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: